Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure

Journal of Pediatrics

Volumn 165, Issue 3, 2014, Pages 440-446

  Wiles, Jason R ^a   Isemann, Barbara ^b   Ward, Laura P ^a,c   Vinks, Alexander A ^a,c   Akinbi, Henry ^a,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CLONIDINE; METHADONE; MORPHINE; OPIATE; PAREGORIC; PHENOBARBITAL; NARCOTIC ANALGESIC AGENT;

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; DRUG ABUSE; HUMAN; INCIDENCE; MEDICAL DECISION MAKING; MOTHER CHILD RELATION; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK MANAGEMENT; VOMITING; WITHDRAWAL SYNDROME; FEMALE; FETOMATERNAL TRANSFUSION; NEONATAL ABSTINENCE SYNDROME; NEWBORN; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION;

ANALGESICS, OPIOID; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84906794639     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.05.010     Document Type: Article

References (60)

1. M. O'Donnell, N. Nassar, H. Leonard, R. Hagan, R. Mathews, and Y. Patterson et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement Pediatrics 123 2009 e614 e621
2. C.L. Wagner, L.D. Katikaneni, T.H. Cox, and R.M. Ryan The impact of prenatal drug exposure on the neonate Obstet Gynecol Clin North Am 25 1998 169 194
3. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795 2013 Substance Abuse and Mental Health Services Administration Rockville (MD)
4. M.J. Hayes, and M.S. Brown Epidemic of prescription opiate abuse and neonatal abstinence JAMA 307 2012 1974 1975
5. L.J. Paulozzi, and Y. Xi Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type Pharmacoepidemiol Drug Saf 17 2008 997 1005
6. A. Kellogg, C.H. Rose, R.H. Harms, and W.J. Watson Current trends in narcotic use in pregnancy and neonatal outcomes Am J Obstet Gynecol 204 2011 259.e1 259.e4
7. S.W. Patrick, R.E. Schumacher, B.D. Benneyworth, E.E. Krans, J.M. McAllister, and M.M. Davis Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009 JAMA 307 2012 1934 1940
8. R. Massatti, M. Falb, A. Yors, L. Potts, C. Beeghly, and S. Starr Neonatal abstinence syndrome and drug use among pregnant women in Ohio: 2004-2011 2013 Ohio Department of Mental Health and Addiction Services Columbus, OH
9. H.E. Jones, K. Kaltenbach, S.H. Heil, S.M. Stine, M.G. Coyle, and A.M. Arria et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure N Engl J Med 363 2010 2320 2331
10. K.J. Anand, D.F. Willson, J. Berger, R. Harrison, K.L. Meert, and J. Zimmerman et al. Tolerance and withdrawal from prolonged opioid use in critically ill children Pediatrics 125 2010 e1208 e1225
11. I. Chasnoff, A. Wells, R. McGourty, and L. Bailey Validation of the 4P's Plus© screen for substance use in pregnancy validation of the 4P's Plus J Perinatol 27 2007 744 748
12. J. Keegan, M. Parva, M. Finnegan, A. Gerson, and M. Belden Addiction in pregnancy J Addict Dis 29 2010 175 191
13. L.M. Jansson, J.A. Di Pietro, A. Elko, E.L. Williams, L. Milio, and M. Velez Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes Drug Alcohol Depend 122 2012 213 219
14. E.M. Wachman, M.J. Hayes, M.S. Brown, J. Paul, K. Harvey-Wilkes, and N. Terrin et al. Association of OPRM1 and COMT Single-Nucleotide Polymorphisms With Hospital Length of Stay and Treatment of Neonatal Abstinence Syndrome JAMA 309 2013 1821 1827
15. D. Chan, J. Klein, and G. Koren New methods for neonatal drug screening NeoReviews 4 2003 e236 e244
16. D. Montgomery, C. Plate, S.C. Alder, M. Jones, J. Jones, and R.D. Christensen Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium J Perinatol 26 2006 11 14
17. M. Coyle, A. Ferguson, L. LaGasse, J. Liu, and B. Lester Neurobehavioral effects of treatment for opiate withdrawal Arch Dis Child-Fetal 90 2005 F73 F74
18. M.L. Velez, L.M. Jansson, J. Schroeder, and E. Williams Prenatal methadone exposure and neonatal neurobehavioral functioning Pediatr Res 66 2009 704 709
19. J. Liu, C. Bann, B. Lester, E. Tronick, A. Das, and L. Lagasse et al. Neonatal neurobehavior predicts medical and behavioral outcome Pediatrics 125 2010 e90 e98
20. B.M. Lester, and L.L. Lagasse Children of addicted women J Addict Dis 29 2010 259 276
21. L.P. Finnegan, J.F. Connaughton Jr., R.E. Kron, and J.P. Emich Neonatal abstinence syndrome: assessment and management Addict Dis 2 1975 141 158
22. P.J. Lipsitz A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy Clin Pediatr 14 1975 592 594
23. M. Green, and F. Suffet The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome Am J Drug Alcohol Abuse 8 1981 203 213
24. W. Zahorodny, C. Rom, W. Whitney, S. Giddens, M. Samuel, and G. Maichuk et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal J Dev Behav Pediatr 19 1998 89 93
25. M.L. Hudak, and R.C. Tan Neonatal drug withdrawal Pediatrics 129 2012 e540 e560
26. A.I. Eidelman, R.J. Schanler, M. Johnston, S. Landers, L. Noble, and K. Szucs et al. Breastfeeding and the use of human milk Pediatrics 129 2012 e827 e841
27. L.M. Jansson ABM clinical protocol# 21: guidelines for breastfeeding and the drug-dependent woman Breastfeed Med 4 2009 225 228
28. M.E. Abdel-Latif, J. Pinner, S. Clews, F. Cooke, K. Lui, and J. Oei Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers Pediatrics 117 2006 e1163 e1169
29. B. Isemann, J. Meinzen-Derr, and H. Akinbi Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome J Perinatol 31 2011 25 29
30. G.K. Welle-Strand, S. Skurtveit, L.M. Jansson, B. Bakstad, L. Bjarko, and E. Ravndal Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants Acta Paediatr 102 2013 1060 1066
31. M. Velez, and L.M. Jansson The opioid dependent mother and newborn dyad: non-pharmacologic care J Addict Med 2 2008 113
32. K. D'Apolito Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants MCN Am J Matern Child Nurs 24 1999 138 144
33. T. Saiki, S. Lee, S. Hannam, and A. Greenough Neonatal abstinence syndrome-postnatal ward versus neonatal unit management Eur J Pediatr 169 2010 95 98
34. Z.G. Hodgson, and R.R. Abrahams A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn J Obstet Gynaecol Can 34 2012 475 481
35. American Academy of Pediatrics Committee on Drugs Neonatal drug withdrawal Pediatrics 101 1998 1079 1088
36. D.A. Osborn, H.E. Jeffery, and M.J. Cole Sedatives for opiate withdrawal in newborn infants Cochrane Database Syst Rev 2010 CD002059
37. M.J. O'Grady, J. Hopewell, and M.J. White Management of neonatal abstinence syndrome: a national survey and review of practice Arch Dis Child Fetal Neonatal Ed 94 2009 F249 F252
38. S. Sarkar, and S.M. Donn Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey J Perinatol 26 2006 15 17
39. D.A. Barrett, D.P. Barker, N. Rutter, M. Pawula, and P.N. Shaw Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions Br J Clin Pharmacol 41 1996 531 537
40. N.J. Bouwmeester, B.J. Anderson, D. Tibboel, and N.H. Holford Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children Br J Anaesth 92 2004 208 217
41. N. Nandakumar, and V. Sankar What is the best evidence based management of neonatal abstinence syndrome? Arch Dis Child Fetal Neonatal Ed 91 2006 F463
42. W.K. Kraft, and J.N. van den Anker Pharmacologic management of the opioid neonatal abstinence syndrome Pediatr Clin North Am 59 2012 1147 1165
43. F. Yang, X. Tong, D.G. McCarver, R.N. Hines, and D.A. Beard Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model J Pharmacokinet Pharmacodyn 33 2006 485 518
44. S. Lainwala, E.R. Brown, N.P. Weinschenk, M.T. Blackwell, and J.I. Hagadorn A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations Adv Neonatal Care 5 2005 265 272
45. C.H. Backes, C.R. Backes, D. Gardner, C.A. Nankervis, P.J. Giannone, and L. Cordero Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting J Perinatol 32 2012 425 430
46. V. Bhatt-Mehta, C.M. Ng, and R.E. Schumacher Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse Pediatr Crit Care Med 15 2014 1 8
47. L. Gowing, R. Ali, and J.M. White Buprenorphine for the management of opioid withdrawal Cochrane Database Syst Rev 2009 CD002025
48. W.K. Kraft, E. Gibson, K. Dysart, V.S. Damle, J.L. Larusso, and J.S. Greenspan et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial Pediatrics 122 2008 e601 e607
49. W.K. Kraft, K. Dysart, J.S. Greenspan, E. Gibson, K. Kaltenbach, and M.E. Ehrlich Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome Addiction 106 2011 574 580
50. M.P. Cober, and C.E. Johnson Stability of an extemporaneously prepared alcohol-free phenobarbital suspension Am J Health Syst Pharm 64 2007 644 646
51. A.G. Agthe, G.R. Kim, K.B. Mathias, C.W. Hendrix, R. Chavez-Valdez, and L. Jansson et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial Pediatrics 123 2009 e849 e856
52. J.B. Leikin, W.P. Mackendrick, G.E. Maloney, J.W. Rhee, E. Farrell, and M. Wahl et al. Use of clonidine in the prevention and management of neonatal abstinence syndrome Clin Toxicol (Phila) 47 2009 551 555
53. H.G. Xie, Y.J. Cao, E.B. Gauda, A.G. Agthe, C.W. Hendrix, and H. Lee Clonidine clearance matures rapidly during the early postnatal period: a population pharmacokinetic analysis in newborns with neonatal abstinence syndrome J Clin Pharmacol 51 2011 502 511
54. B. Surran, P. Visintainer, S. Chamberlain, K. Kopcza, B. Shah, and R. Singh Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial J Perinatol 33 2013 954 959
55. D. McVay, V. Schiraldi, and J. Ziedenberg Treatment or incarceration? National and state findings on the efficacy and cost savings of drug treatment versus imprisonment 2004 Justice Policy Institute Washington, DC
56. H.E. Jones, L.M. Jansson, K.E. O'Grady, and K. Kaltenbach The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations Neurotoxicol Teratol 39 2013 110 115
57. D. Campa, A. Gioia, A. Tomei, P. Poli, and R. Barale Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief Clin Pharmacol Ther 83 2008 559 566
58. T.T. Rakvag, J.R. Ross, H. Sato, F. Skorpen, S. Kaasa, and P. Klepstad Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain Mol Pain 4 2008 64
59. Truven Health Analytics. Micromeex Solutions Redbook. http://micromedex.com/redbook. Accessed January 30, 2014.
60. J.R. Wiles, A.A. Vinks, and H. Akinbi Federal legislation and the advancement of neonatal drug studies J Pediatr 162 2013 12 15